These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2534415)

  • 1. Pump performance after regression of cardiac hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; de Almeida JB; Amorim MP; Portela J; Cezaretti ML; Ramos OL
    J Hypertens Suppl; 1989 Dec; 7(6):S288-9. PubMed ID: 2534415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy in the short-term treatment of hypertension with isradipine.
    Saragoça MA; Portela JE; Abreu P; Plavnik F; Vanneta A; Ajzen H; Ramos OL
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):188S-190S. PubMed ID: 1827018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new calcium antagonist isradipine. Effect on blood pressure and the left ventricle in black hypertensive patients.
    Carr AA; Prisant LM
    Am J Hypertens; 1990 Jan; 3(1):8-15. PubMed ID: 2137344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension.
    Dahlöf B
    Am J Med; 1989 Apr; 86(4A):19-26. PubMed ID: 2523651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals.
    Sauter A; Rudin M
    Am J Med; 1989 Apr; 86(4A):130-3. PubMed ID: 2523648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of isradipine in essential hypertension.
    Grossman E; Messerli FH; Oren S; Nunez B; Garavaglia GE
    Am J Cardiol; 1991 Jul; 68(1):65-70. PubMed ID: 1829320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and hemodynamic effects of isradipine in essential hypertension.
    Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M
    Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac effects of isradipine in patients with hypertension.
    Lund-Johansen P
    Am J Hypertens; 1993 Jul; 6(7 Pt 2):294S-299S. PubMed ID: 8398014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of cardiac hypertrophy after therapy in animal hypertension.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S56-61. PubMed ID: 2409372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of calcium channel blockers as ventricular unloading agents.
    Guazzi MD; Cipolla C; Sganzerla P; Agostoni PG; Fabbiocchi F; Pepi M
    Eur Heart J; 1983 Jan; 4 Suppl A():181-7. PubMed ID: 6220895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats.
    Mitchell GF; Pfeffer MA; Finn PV; Pfeffer JM
    Circulation; 1996 Dec; 94(11):2923-9. PubMed ID: 8941122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of reversal of hypertensive cardiac hypertrophy by captopril on left ventricular pumping ability and performance.
    Saragoça MA; Cezaretti ML; Bessa AM; Casarini D; Almeida JB; Amorim MP; Ramos OL
    J Hypertens Suppl; 1987 Dec; 5(5):S403-6. PubMed ID: 2965226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reversal of left ventricular hypertrophy with control of blood pressure in experimental hypertension.
    Fernandez PG; Snedden W; Idikio H; Fernandez D; Kim BK; Triggle CR
    Scand J Clin Lab Invest; 1984 Dec; 44(8):711-6. PubMed ID: 6098957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond lowering of blood pressure. . .isradipine. Satellite symposium of the thirteenth scientific meeting of the International Society of Hypertension.
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):83S-209S. PubMed ID: 1827025
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isradipine for treatment of acute hypertension after myocardial revascularization.
    Brister NW; Barnette RE; Schartel SA; McClurken JB; Alpern J
    Crit Care Med; 1991 Mar; 19(3):334-8. PubMed ID: 1825628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.